With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
We are looking for a highly experienced medicinal chemist at Senior Principal Scientist level. As a key part of our Chemical Sciences team, you will be responsible for working closely with senior cheminformatics, AI, machine learning, engineering and product development leaders to help shape the development of our proprietary computational platform to maximise its impact on Drug Discovery programmes at all stages from target identification through to Candidate selection.
Our state-of-the-art platform utilises novel machine learning, cheminformatic and computational chemistry techniques to transform the way targets and binding sites are prioritised, early hit matter is identified and complex molecular optimisations across ADMET space are performed. Working closely with the senior product manager, the candidate will bring their wide-ranging experience and knowledge of Drug Discovery to help prioritise the development of our platform to best impact on our diverse portfolio.
As an experienced medicinal chemist, a further part of the role will be direct contribution to programmes from Hit Identification through to Candidate delivery in either a chemistry or project leadership capacity.
The successful Candidate will be working to support small molecule Drug Discovery at our headquarters in London devising creative ways to reimagine the way medicines are discovered.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email email@example.com. Thank you.